Ignite Creation Date:
2024-05-06 @ 7:35 PM
Last Modification Date:
2024-10-26 @ 3:10 PM
Study NCT ID:
NCT06068881
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-03
First Post:
2023-09-29
Brief Title:
A Study to Assess Efficacy and Safety of Oral Tazemetostat in Adult Participants With RelapsedRefractory Follicular Lymphoma That Does Not Have an EZH2 Gain-of-function Genetic Mutation
Sponsor:
Organization:
Ipsen
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
55
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: